Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Mfsd2a KO mice have decreased liver TG with normal liver metabolism. by Justin H. Berger (297156)

Hematopoietic potential decreases in ESC with down-regulation of junction molecules. by Basha L. Stankovich (207031)

“…Error bars represent standard error of mean. C) TF expression level linearly correlates with decreased frequency of CD45+ cells. …”

Fig 5 - by Mestewat Simeon (19233200)

Decreases in locomotor responses to a single METH injection in <i>Ptprz</i>-KO mice. by Akihiro Fujikawa (122649)

Reduced I_A decreases the stimulus threshold for short-term synaptic plasticity. by Ángela Fontán-Lozano (193161)

Treatment with DHA and DHA/HTF decreased Jurkat cell viability. by Qiuyan Wang (237527)

Effects of GM-CSF on DMN-induced hepatotoxicity. by Mrigendra Bir Karmacharya (13607415)

2-ME decreases blood pressure in Sprague Dawley rats. by Weiyu Chen (2216251)

Increased apoptosis and decreased invasion in MCPH1 overexpressing cells. by Thejaswini Venkatesh (385655)

HDACi exposure in DHA-treated cells enhanced decreases of Mcl-1 and p-ERK. A. by Chris Zhiyi Zhang (111721)

53BP1 protein abundance decreases upon irradiation. by Yiheng Hu (648082)

Sudachitin decreases osteoclastogenesis induced by RANKL in cultures of osteoclast precursors. by Yoko Ohyama (4775400)

Decreasing bioavailable copper in vivo modulates tumor vessel dimensions. by Andrew Crowe (450839)

The effects of NAC on the decreased number of myotube formations caused by arecoline. by Yi-Xuan Li (6633845)

Protein and mRNA expression of Glo-I in pHEP, pHSC and pLSEC in controls, early and advanced cirrhosis. by Marcus Hollenbach (376231)

Overexpression of Lethe in RAW macrophage cells decreases ROS production. by Carlos Zgheib (311460)

UVB irradiation decreased TM expression in HaCaT cells. by Huey-Chun Huang (429098)

“…<p>(A) HaCaT Cells were exposed to UVB irradiation in a dose-response (0, 1.5, 3, 4.5, 6 mJ/cm²) Cell viability was examined by trypan blue exclusion. …”

The utility of Hmp for NO• consumption and tolerance decreases with increased NO• delivery rate. by Jonathan L. Robinson (409406)